Concepedia

Marek Čierny

MČ

Statistics

Publications

7

Citations

1.2K

H-Index

7

Active since

2017

Affiliations

Stanford University(Current)

Fondazione IRCCS Istituto Neurologico Carlo Besta

University of Pennsylvania

University of Kansas Medical Center

Alexion Pharmaceuticals (United States)

Marek Čierny is an author at Stanford University specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Publications per year

2017–2024

7

Publications

7

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

, , +6

Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy

Hooman Kamel, W. T. Longstreth, David Tirschwell et al. · JAMA · 2024 · 181 citations · Full text

, , +17

Endovascular Thrombectomy for Large Ischemic Stroke Across Ischemic Injury and Penumbra Profiles

Amrou Sarraj, Ameer E Hassan, Michael Abraham et al. · JAMA · 2024 · 96 citations · Full text

, , +17

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

, , +9

Eculizumab improves fatigue in refractory generalized myasthenia gravis

Henning Andersen, Renato Mantegazza, Jing Jing Wang et al. · Quality of Life Research · 2019 · 56 citations · Full text

, , +14

1–5 of 7